"10.1371_journal.pone.0137822","plos one","2015-09-14T00:00:00Z","Yu-Na Lee; Min-Chul Kim; Young-Tae Lee; Hye Suk Hwang; Jongsang Lee; Cheol Kim; Sang-Moo Kang","Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia 30303, United States of America; Animal and Plant Quarantine Agency, Anyang, Gyeonggi-do, South Korea; BEAMS Biotechnology Co. Ltd., Seongnam, Gyeonggi-do, South Korea","Conceived and designed the experiments: YNL SMK. Performed the experiments: YNL MCK YTL HSH. Analyzed the data: YNL MCK SMK. Contributed reagents/materials/analysis tools: JL CK. Wrote the paper: YNL SMK.","SMK and MCK are inventors in the pending patents on universal influenza vaccine based on heterologous multiple M2e proteins. The authors also declare that co-author SMK is a PLOS ONE Editorial Board member. JL and CK are employees of the Beams. The authors (SMK, MCK) are listed as inventors in the following patent filed. US Patent 61/738,139: “Universal Influenza Vaccine based on heterologous multiple M2e proteins”. US Application No.: 61/722,602 (Filing Date: November 5, 2012). US Application No.: 61/738,139. The authors confirm that this does not alter their adherence to all PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2015","09","Yu-Na Lee","YNL",7,TRUE,2,4,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
